Anti-EGFR single-chain antibody fusion Gelonin recombination immunotoxin, preparation method and usage thereof
An immunotoxin and single-chain antibody technology, applied in the biological field, achieves obvious effects, simple and convenient preparation, and less toxic and side effects
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0023] Embodiment 1 The preparation of the fusion toxin of the present invention
[0024] The heavy chain and light chain variable regions of the antibody were amplified from known anti-EGFR hybridomas to construct anti-EGFR single-chain antibodies, and ribosome display technology was used for specificity identification and affinity evolution. Gelonin and the obtained single-chain antibody gene were constructed as a fusion gene, and then expressed in Escherichia coli.
[0025] Specifically: extract total RNA from anti-EGFR hybridoma cells (preserved in our laboratory), and then use RT-PCR method to amplify Anti-EGFR heavy and light chains (VH, VL) according to the designed library construction and specific primers For the gene, the band with good amplification effect was selected for gel recovery and inserted into the T vector. The ligation product was transformed into DH5a, a large number of single colonies were picked, plasmids were extracted, and sent for sequencing. The ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com